antioxidants Review Green Tea and Other Tea Polyphenols: Effects on Sebum Production and Acne Vulgaris SuzanaSaric1,ManishaNotay2andRajaK.Sivamani2,* 1 SchoolofMedicine,UniversityofCalifornia—Davis,Sacramento,CA95817,USA;[email protected] 2 DepartmentofDermatology,UniversityofCalifornia—Davis,Sacramento,CA95816,USA; [email protected] * Correspondence:[email protected];Tel.:+1-916-703-5145 AcademicEditors:AlessandraNapolitanoandStanleyOmaye Received:15August2016;Accepted:26December2016;Published:29December2016 Abstract:Polyphenolsareantioxidantmoleculesfoundinmanyfoodsincludingnuts,fruits,vegetables, chocolate, wine, and tea. Polyphenols have antimicrobial, anti-inflammatory, and antineoplastic properties. Recentstudiessuggestthatteapolyphenolsmaybeusedforreducingsebumproduction intheskinandfortreatmentofacnevulgaris.Thisreviewexaminestheevidenceforuseoftopically andorallyingestedteapolyphenolsagainstsebumproductionandforacnetreatmentandprevention. The PubMed database was searched for studies on tea polyphenols, sebum secretion, and acne vulgaris. Of the 59 studies found, eight met the inclusion criteria. Two studies evaluated tea polyphenoleffectsonsebumproduction;sixstudiesexaminedteapolyphenoleffectsonacnevulgaris. Seven studies evaluated topical tea polyphenols; one study examined systemic tea polyphenols. Noneofthestudiesevaluatedbothtopicalandsystemicteapolyphenols. Teapolyphenolsources included green tea (six studies) and tea, type not specified (two studies). Overall, there is some evidencethatteapolyphenolsintopicalformulationmaybebeneficialinreducingsebumsecretion andintreatmentofacne. Researchstudiesofhighqualityandwithlargesamplesizesareneeded toassesstheefficacyofteapolyphenolsintopicalandoralpreventionofacnevulgarisandlipid synthesisbythesebaceousglands. Keywords: tea;polyphenol;EGCG;catechin;sebum;acnevulgaris 1. Introduction Polyphenolsarenaturallyoccurringcompoundsfoundinplantsandcommonfoodssuchasnuts, fruits,vegetables,chocolate,wine,andtea. Afteringestion,polyphenolsareabsorbedintheintestinal epithelium[1]andhavebeenshowntoreachsystemiccirculation[2–5]. Polyphenolsareantioxidants and play a role in preventing oxidative damage caused by the reactive oxygen species (ROS) [6]. Theypossessanti-inflammatory[7]andanti-carcinogenicpropertiesandmayaidinthepreventionof cardiovasculardisease[8],aswellasprotectskinfromultravioletradiation(UVR)[9–11]. Tea is the second most consumed beverage worldwide and an important source of plant polyphenols in the human diet [12]. Camellia sinensis is the plant that gives rise to a variety of teas depending on specific processing of the plant [13]. Green tea is produced from fresh leaves in such a way thatprevents oxidationof polyphenolic components (mainly catechins), oolong tea polyphenols are partially oxidized, while polyphenols in black tea undergo a high degree of oxidation[13]. Componentsofgreenteabeveragemeasuredasweightpercentageofextractsolids include 30%–42% catechins, 5%–10% flavonols, and 2%–4% other flavonoids [13]. Catechins are dividedintocatechin(C),(−)-epicatechin(EC),(−)-epicatechingallate(ECG),(−)-epigallocatechin (EGC), and (−)-epigallocatechin-3-gallate (EGCG) (Figures 1 and 2). EGCG is the most abundant catechinandhasbeenshowntohavebeneficialhealtheffectsonskin[12]. Antioxidants2017,6,2;doi:10.3390/antiox6010002 www.mdpi.com/journal/antioxidants Antioxidants2017,6,2 2of16 Antioxidants 2017, 6, 2 2 of 16 Antioxidants 2017, 6, 2 2 of 16 Figure 1. Major components of the tea polyphenol family. Figure1.Majorcomponentsoftheteapolyphenolfamily. Figure 1. Major components of the tea polyphenol family. (a) (b) (a) (b) (c) (d) (c) (d) (e) (e) Figure 2. Chemical structures of major tea polyphenols. (a) (+)-Catechin (C); (b) (−)-Epicatechin (EC); FiguFr(eicg) 2u(.r−e)C -2Eh. pCeicmhaetimeccaihclainsl t srgturaucllctaututrere es(sE ooCffG mm);a aj(ojdor) rt e(ta−e )pa-Eopplyoigplahyleplonhcoealsnte. oc(ahls)i .n(+ ()(a-EC)Ga(Ct+e))c;- hC(iena) t (eC(−c))h; -(Eibnp) i((gC−a))l-l;Eop(cbaict)aet(ce−hcih)n-i Eng p(aEilclCaa)tt;e e chin ((cE) G(C−)G-E)p. icatechin gallate (ECG); (d) (−)-Epigallocatechin (EGC); (e) (−)-Epigallocatechin gallate (EC); (c) (−)-Epicatechin gallate (ECG); (d) (−)-Epigallocatechin (EGC); (e) (−)-Epigallocatechin (EGCG). gallate(EGCG). Antioxidants2017,6,2 3of16 Sebaceous glands are found throughout the human body, especially on the face and scalp, and they produce sebum—a mixture of lipids [14]. Lipids are produced by other glands in the body but the two most specific lipids to sebaceous glands are squalene and wax esters [14]. Sebum secretion is associated with hormonal activity in the human body [15] and excess sebum production is implicated in the development of skin disorders, such as acne vulgaris. Acne is not alifethreateningconditionbutitcanleavepermanentscaringonthefaceandcausephysicaland psychologicalmorbidities[16]. Acnemaybecausedbymultiplemechanismsincluding(a)increased sebumproductionbythesebaceousglands;(b)alteredkeratinizationwithinpilosebaceousfollicles; (c)proliferationofbacteriaPropionibacteriumacnes(P.acnes);and(d)inflammationaroundpilosebaceous follicles[16,17]. Recent evidence suggests that there is increased phosphoinositide 3-kinase-Akt-mammalian target of rapamycin complex 1 (PI3K-Akt-mTORC1) signaling in the skin of patients with acne vulgaris [18–20] and that increased PI3K-Akt-mTORC1 signaling induces sebum production [21]. Thegreentea-derivedplantsterolshaveshownatherapeuticroleinthetreatmentofacnevulgaris[22]. Im et al., 2012 provided experimental evidence that EGCG treatment of insulin growth factor (IGF-1)stimulatedSZ95sebocytesdecreasedmTORphosphorylationandthusmTORC1activity[23]. Additionally,VanAlleretal.,2011[24]providedevidencethatEGCGisanATP-competitiveinhibitor ofbothPI3KandmTOR.MoleculardockingstudiesshowedthatEGCGbindswelltothePI3Kdomain activesite,agreeingwiththefindingsthatEGCGcompetesforATPbinding. ThemTORkinasealso belongs to the family of PI3K related kinases. Increased insulin-IGF-1 signaling in acne vulgaris activates PI3K-Akt-mTORC1 signaling cascade and plays a key role in the Western-diet induced acne[25]. NaturalmTORC1inhibitors,suchasgreenteapolyphenols,attenuateenhancedmTORC1 signaling[26]. Whencomparedwithothertypesoftea,greenteahasthehighestpolyphenoliccontent, withEGCGandEGCcomponentsbeingthemostabundant[27]. Therearemultipleacnegradingsystemsbutthereisnogoldstandard[28]thatisconsistently usedinclinicalpracticeorresearchtrials. Lesioncountinghasbeenvalidatedasareliablemeasure for acne [29] and requires counting the number of comedones, papules, pustules, and nodules on the face [30]. The global assessment scale classifies acne into one of five categories based on acne severity(verymild,mild,moderate,severe,andverysevere)[30]. IntheLeedstechnique,asubject’s acneiscomparedtoaphotographicmanualandascorefrom1(mild)to10(verysevere)isassigned[30]. TheGlobalAcneGradingSystem(GAGS)wasdevelopedin1997inanefforttoimproveaccuracy, minimizeinter-andintra-ratervariability,andallowforquickerassessments[30]. Due to the complex nature of acne vulgaris, most treatments have only modest efficacy [31]. Systemictherapiesthatinfluencesebumproductionincludeestrogens,anti-androgens(i.e.,spironolactone), retinoid (isotretinoin), and oral contraceptives [32]. All these medications predispose individuals topotentiallyserioussideeffects,thusthereisaneedformorenaturaltherapieswithminimalside effects. Researchsuggeststhatteapolyphenolsmaybepromisinginthemanagementofacnevulgaris byreducingsebumproductionintheskinandactingasananti-inflammatory[7]andantimicrobial agents [33]. In an invitro study, Yoon et al., 2013 [31] showed that EGCG decreases lipogenisis in sebocytes,inhibitsgrowthofP.acnesandreducesinflammationcausedbyP.acnes. Theaimofthis reviewistoexaminerecentclinicaltrialsonteapolyphenolsandtheireffectsonsebumproduction andacnevulgarismanagement. 2. MaterialsandMethods 2.1. SearchStrategy On 4 August 2016 the PubMed database was searched for studies that investigated tea polyphenols,sebumproduction,andacne. Nolimitswereplacedonthepublicationdate. Thesearch combined keywords “tea”, “green tea”, “EGCG”, “polyphenol”, “catechin”, “sebum” and “acne”. Nofilterswereselected. Antioxidants2017,6,2 4of16 2.2. SelectionofStudies Records were screened by title and/or abstract to exclude studies that did not contribute to answeringthequestioninthisreview. Inclusioncriteria: (1)publishedinEnglish;(2)intervention includedateapolyphenol;(3)humanstudy. Exclusioncriteria: (1)invitrostudies;(2)animalstudies; (3)reviewarticles. 2.3. DataExtraction Datawasextractedfromselectedstudies(TableA1)asfollows: (1)tea;(2)polyphenolsubtype andcontent;(3)therapy(topicalorsystemic;dosage);(4)comparison(orcontrol/placebo);(5)subjects (n,age);(6)studydesign,duration;(7)majoroutcomemeasures;(8)majorresults;(9)adverseevents; (10)reference. 3. Results Our search yielded a total of 59 studies. Titles and/or abstracts were screened for inclusion andexclusioncriteria. Eightarticlesmetthecriteriaandweresubsequentlyanalyzed. Twostudies examined the effects of tea polyphenols on sebum production, while six studies investigated the effects of tea polyphenols on acne vulgaris. Seven studies examined the application of topical tea polyphenolsandonestudyexaminedsystemicteapolyphenols. Noneofthestudiesexaminedboth topicalandsystemicteapolyphenols.Teapolyphenolsourcesincludedgreenteainsixstudies,whilein twostudiestheteatypewasnotspecified. 3.1. SebumProductionStudies Inasingle-blinded,placebocontrolledmonocentricstudybyMahmoodetal.,2013[15]conducted inPakistan,22non-smoker,healthymenaged22–28years-oldwereenrolledtoinvestigatetheeffects ofgreenteaandlotusextracttopicalsonfacialsebumproduction. Thiswasasplitbodycomparative studyinwhichonegroupusedgreentea(GT)topicalononecheekandplacebocontrolontheother (n=11). Thesecondgroupusedtopicalgreenteaandlotus(GT-L)ononecheekandplacebocontrol ontheother(n=11). TheGTtopicalconsistedof5%greenteaandtheGT-Lformulationcontained 2.5%greenteaand2.5%lotusextract. Bothgroupswereinstructedtoapplytheirrespectivetopicals atbedtimefor60days. Sebumeterwasusedtomeasuresebumsecretiononbothcheeksatbaseline anddays15,30,45,and60. After60days,theGTtopicalgrouphadasignificantreductioninsebum secretion from baseline, compared to placebo control (27% reduction, p = 0.006). The GT-L group also had a significant reduction in sebum secretion from baseline to day 60 compared to placebo control(25%reduction,p=0.002). TherewerenoadverseeventsreportedineitherGTorGT-Lgroup. ThisstudyshowedthatGTandGT-Ltopicalswerebotheffectiveinsignificantlyreducingsebum secretion. Additionally,eventhoughtheGT-LcombinationtopicalhadasmallerpercentageofGT extract(2.5%vs. 5%inGTgroup),GT-LreducedsebumsecretiontoahigherdegreethanGTtopical alone; this could indicate an additive effect of GT and L extracts. These findings suggest that GT andGT-Lcombinationtopicalscouldbeusedtotreatskindiseasesthatareassociatedwithincreased sebumsecretion,suchasacnevulgaris. Limitationsofthisstudyincludeasmallsamplesizeandthatit onlyincludedhealthymen.Futurestudiesshouldfocusonstudyingtheeffectsofthetwoformulations inpatientswithacnevulgaris. InastudybyMahmoodetal., 2010[34], tenhealthymenage24–40years-oldapplied3%GT topical to their cheeks for eight weeks. A sebumeter was used to measure the amount of sebum secretionat1,2,3,4,and8weekswhichwasusedtocalculatethepercentchangeinsebumproduction from week 1 to week 8. The results showed that the 3% GT topical led to a significant reduction in sebum production during the 8 week study period (p < 0.05). Specifically, sebum production decreasedbynearly10%inthefirstweekandasmuchas60%byweek8. Nosideeffectswerenoted. Antioxidants2017,6,2 5of16 Limitationsofthisstudyincludesmallsamplesize,nocomparisontreatmentorplacebocontrol,andit didnottestindividualswithskindiseasesknowntohavehighsebumproduction. 3.2. AcneStudies 3.2.1. TopicalTeaPolyphenols Sharquieetal.,2008[35]conductedasingle-blindrandomizedclinicaltrialexamining2%tea lotionand5%zincsulphatesolutionintreatmentofacnevulgaris. Theteatypewasnotspecified. Forty-sevensubjects(33women,14men)aged13–27years-oldwereenrolledbetweenJune2006and December2007inIraq. Subjectswererandomlyassignedoneoftwogroups: 2%tealotion(n=24) or 5% zinc sulphate solution (n = 23); both groups applied their respective topical twice daily for 2months. Inflammatorylesioncountingwasperformedevery2weeksandgradedasfollows: mild acne(<20pustulesand<10papules)andmoderateacne(20–40pustulesand>30papules). Itwas consideredthatsubjectshada“goodresponse”totreatmentiftheinflammatorylesioncountdecreased by>50%;“moderateresponse”whendecreasewas10%–50%;and“noresponse”whenlesioncount decreased by <10%. The 2% tea lotion group experienced a significant reduction in inflammatory lesioncount(papulecountdecreasewithtreatment,p=0.0001;pustulecountdecreasewithtreatment, p=0.003). Eighty-fivepercentofsubjectshadagoodormoderateresponseand15%hadnoresponse totreatment. Therewasnosignificantdifferenceininflammatorylesioncount(papuleorpustule)in thegrouptreatedwith5%zincsulphatecomparedtobaseline. Adverseeventreportedbythe2%tea lotion group was mild itching (5 subjects) at the beginning of the treatment period. The 5% zinc sulphategroupalsoreporteditching(2subjects),aswellasburningsensation(5subjects). Noserious side effects were reported in either group. One limitation of this study is the small sample size (n=20ineachgroupthatcompletedthestudy). Nevertheless,2%tealotionispromisingforitseffect ofdecreasinginflammatorylesioncount. Futurestudiescouldbedonetocompareittootherknown topicaltreatmentsforacnetofurtherassessitsefficacyandsafetyprofile. Arandomly-assignedsplitbody(face)trialwasconductedbyYoonetal.,2013[31]toexamine theeffectivenessof1%EGCGand5%EGCGtopicalscomparedtovehiclecontaining3%ethanolin decreasingacnelesioncount.Eachgroupappliedtheassignedtopicaltoonesideoftheface(1%EGCG or5%EGCG);bothgroupsappliedthevehicletopicaltotheothersideofface. Non-inflammatory and inflammatory lesions were counted. A revised Leeds score, which represents inflammatory and non-inflammatory acne counts, was used as a global assessment of acne severity. The mean Leeds score at baseline was 5.1 ± 0.4. At eight weeks, the mean Leeds score for the 1% EGCG groupwas1.2±0.4andforthe5%EGCGgroupitwas1.7±0.6. ThereductioninLeedsscorewas significantinboth1%EGCGand5%EGCGgroups(p<0.05). Specifically,non-inflammatorylesions reducedby79%andinflammatorylesionsby89%aftereightweeksof1%EGCGusecomparedto baseline(p<0.05). Thenon-inflammatoryandinflammatorylesionreductionwassimilarin5%EGCG group(p<0.05),however,thespecificlesioncountsandpercentageimprovementwerenotprovided. Overall,thisstudyshowedthat1%and5%EGCGwerebotheffectiveinimprovingacnevulgaris withoutmajorsideeffects. Asingle-blindrandomizedcontrolledstudybySharquieetal.,2006[36]investigatedtheeffects of2%tealotioncomparedtoplacebolotioninitsabilitytodecreaseacnelesioncount. Sixtysubjects, aged14–22years-old(35women,25men)participatedinthestudyforadurationof2monthsbetween October 2002 and October 2004 in Iraq. The treatment group applied 2% tea lotion twice a day for 2 months and inflammatory lesion count (papules and pustules) was done at weeks 4 and 8. Thecontrolgroupunderwentthesameprocedurebutusedacontrollotion,whichconsistedofdistilled water. The2%tealotiongrouphadasignificantdecreaseininflammatorylesioncountat8weeks post-treatment (baseline papules 12 ± 3.3, week 8 papules 8.1 ± 19, p < 0.001; baseline pustules 20.7±5.8,week8pustules8.9±2.3,p<0.001). Eighty-eightpercentofsubjectsinthetreatmentgroup reported being fully or partially satisfied with the treatment outcome and 12% were not satisfied. Antioxidants2017,6,2 6of16 Thecontrolgroupdidnothaveasignificantreductioninlesioncountat8weekscomparedtobaseline. Inthisgroup,83.3%ofsubjectswerenotsatisfiedwiththeoutcomeand16.7%werepartiallyorfully satisfied. Therewerenoadverseeventsreported. Thisstudysuggeststhat2%tealotionisaneffective topicalalternativeinacnemanagement. Elsaieetal.,2009[37]studiedtheeffectivenessof2%greentealotioninreducingacneseverity. The study had 20 subjects, aged 15–36 years-old (14 women, 6 men) and was conducted in Egypt betweenMay2007andFebruary2008. Acneseveritywasassessedatbaselineviatotallesioncount (TLC)forpustulesandpapulesandseverityindex(SI).TheTLCatbaselinewasconsidered100% and any decrease during treatment was considered an improvement. Baseline images were taken and subjects were instructed to apply the 2% green tea lotion twice daily for 6 weeks with follow upevery2weeks. TheresultsshowedameanTLCdecreasefrom24(baseline)to10after6weeks oftreatment(58.33%reduction,p<0.0001,95%confidenceinterval(CI)=8.58–19.42). ThemeanSI alsodecreasedfrom2.05(baseline)to1.25after6weeksoftreatment(39.02%reduction,p<0.0001, 95%CI=0.54–1.26). Fivesubjectsreportedstingingsensationoritching,buttheseresolvedwithin 2–3daysoftreatment. Smallsamplesizeandlackofcomparison,orcontrolgroup,werelimitations inthisstudy. Thetrueeffectofthetopicalgreentealotionwasnotclearwiththelackofacontrol treatment. Nevertheless,itshowedthat2%greentealotioncouldbebeneficialinacnetreatmentby reducingacnelesioncountandwarrantsfuturecontrolledstudies. In a study by Jung et al., 2012 [38] conducted in Korea, a green tea extract compound called polyphenon-60wasusedtoexamineitspotentialtherapeuticeffectsonacnevulgaris. Sixtysubjects withmildtomoderateacneapplied20mg/mLpolyphenon-60twicedailyfor8weeks; theiracne lesioncountwasassessedatbaselineandweek8. Eightweekspost-treatmentwithpolyphenon-60, therewasa61%decreaseinopencomedones(p<0.05)and28%decreaseinthenumberofpustules (p<0.05)comparedtobaseline. Therewasnosignificantdecreaseinthenumberofclosedcomedones atweek8comparedtobaseline.Nomajoradverseeventswerenoted.Thisstudydidnothaveacontrol grouporcontroltreatment. 3.2.2. SystemicTeaPolyphenols Luetal.,2016[39]conductedarandomized,double-blind,placebocontrolledtrialtoinvestigate whether systemic green tea supplementation could improve acne in post-adolescent women. The study enrolled 80 women aged 25–45 years-old with moderate to severe acne, as determined by the Investigators Global Assessment score of 3 or 4 (scale 0–5). The study was conducted in Taiwan between May 2012 and October 2013. One group (n = 40) received 1500 mg decaffeinated greenteadaily(1capsule500mgGT30minaftermeal,3timesdaily)forfourweeks. Thesecond group received cellulose capsules (placebo), which looked identical to GT capsules for blinding purposes. Ablindeddermatologistrecordedinflammatoryandnon-inflammatorylesioncountsonthe forehead,cheeks,nose,perioralarea,chin,andentirefaceatbaselineandatfourweekspost-treatment. Therewasasignificantdecreaseintheinflammatorylesioncountsonthenose(p=0.03),perioralarea (p=0.04), and chin (p=0.03) in the green tea group compared to placebo group. There was no significant difference in lesion counts on forehead, cheek, or in the total lesion count between GT and placebo groups. Within the GT group, subjects had significantly lower inflammatory lesion countsontheforehead(p=0.04)andcheeks(p=0.04),aswellaslowertotallesioncount(p=0.03)at theendoftreatmentcomparedtobaseline. Withintheplacebogroup,therewassignificantdecreasein inflammatorylesioncountoncheeks(p=0.01)andchin(p=0.01),aswellastotallesioncount(p=0.02). Adverseeventsincludedmildconstipationandabdominaldiscomfort(threesubjects). Placebogroup adverseeventsincludedthirstanddifficultyfallingasleep(twosubjects). However,nomajorside effectswerereported. EventhoughdecaffeinatedGTtreatmentresultedindecreasedlesioncounts onnose,perioralarea,andchincomparedtoplacebo,theplacebogroupitselfhadsignificantwithin groupdifferenceinlesioncountsbeforeandaftertreatment. Additionalstudieswithmoresubjects andlongerdurationareneededtoassesstheeffectivenessofsystemicgreenteaintreatmentofacne. Antioxidants2017,6,2 7of16 4. Discussion Polyphenols are naturally occurring compounds found in many common foods and plants, including Camellia sinensis [13], the plant that gives rise to a variety of teas. Their natural-based ingredients,costeffectivenessandnon-invasiveattributeshavemadethemincreasinglyattractive to patients, compared to prescription drugs [40], and this has led to an increase in polyphenol studies examining their effects on the skin. In this review, we include eight studies focusing on teapolyphenolsandtheireffectsonsebumproductionandacne. Alleightstudiesreportedthattea polyphenolswereeffectiveateitherreducingsebumproductionorimprovingacneseverityinatleast oneoutcomemeasure. 4.1. TeaPolyphenolBioavailability Bioavailability of polyphenols varies depending on the polyphenol forms within the dietary source[41].EGCG,themostabundantcatechinfoundintea,isprimarilyabsorbedinthesmallintestine andmetabolizedbycolonicflorainthelargeintestine[42]. Studiesshowthatbioavailabilityvaries amongcatechinswhereEGCGisreadilypresentinplasmaafterintake,indicatinghighbioavailability, whereas galloylated catechins have never been recovered in urine samples [41]. Fasting, fish oils, albumin, soft water, piperine, Vitamin C and storage in cool and dry conditions can increase the oral bioavailability of EGCG [42]. Oral bioavailability is reduced by oxidation with air, metal ions,catechol-O-methyltransferase(COMT)polymorphisms,andgastrointestinalinactivation[43]. Yangetal.,1998[44]showedthatmaximalEGCG,EGC,andECplasmaconcentrationwasreached between1.5and2.5hafterconsumptionofgreentea,andtheybecameundetectableinplasmaafter24h. Studieshavefoundextensivevarianceinbioavailabilityacrosspolyphenols,includingteapolyphenols, whichmaybedrivenbythenatureofstudysubjectdietsandtheirlevelsofmetabolizingenzymes[41]. Therefore,futurestudiesareneededtofurtherinvestigatebioavailabilityofteapolyphenols. 4.2. SkinPenetration ThepartitioncoefficientsofteapolyphenolsareshowninTable1[45].EGCisthemosthydrophilic molecule,whileECGistheleastpolar[45].AstudybydalBeloetal.,2009[46]investigatedapplication of6%greenteaextractonthehumanskinobtainedfromabdominalsurgery. Theresultsshowedthat EGCGwasretainedwithintheskin,withhigherlevelsofEGCGdetectedinthestratumcorneum, followed by the epidermis and dermis. This suggests that EGCG is more non-polar as non-polar compounds tend to stay in the stratum corneum rather than get into the epidermis and dermis. Additionally,astudybyZillichetal.,2013[47]usedexvivopigskinandshowedthatbothsizeof themoleculeandhydrophobicityofthemoleculeimpactskinpermeationofgreenteacompounds. However,studiesonhumanskinpenetrationbyteapolyphenolsarelimitedinnumberandfurther researchinthisareaiswarranted. Table1.Partitioncoefficientsofgreenteapolyphenols. Polyphenol K(non-polar/polar) Epicatechingallate(ECG) 6.25 Epigallocatechingallate(EGCG) 2.94 Epicatechin(EC) 2.38 Catechin(C) 2.33 Epigallocatechin(EGC) 0.93 4.3. Tolerability Overall,studiesshowthattopicalandsystemicteapolyphenolstendtobewelltolerated. Astudy by Elsaie et al. [37] showed minimal side effects to 2% green tea topical. Ten percent of subjects experienced stinging, which resolved within 48 h, and 15% of subjects experienced local pruritus, whichresolvedbydaythree. InastudybyLuetal.,2016[39],systemicgreenteawasgiventosubjects Antioxidants2017,6,2 8of16 threetimesdailyforfourweeksandthisregimenwaswelltolerated.Onesubjectexperiencedmild constipationandtwoothersexperiencedmildabdominalpain.Oftheeightstudiesincludedinthisreview, nonereportedmajoradverseeventsandtheteapolyphenolsweregenerallywelltoleratedintopicaland systemicformulations.Furtherstudiesinvestigatingtheimpactofvariousdosagesshouldbeconsidered. 4.4. MechanismsofAction Acne is thought to be due to the activity of bacteria called Propionibacterium acnes (P. acnes), sebum production by the sebaceous gland, keratinization of the follicular keratinocytes, and inflammation [17]. Various mechanisms of action for the clinical efficacy of tea polyphenols in reducing acne severity have been suggested. P. acnes [48], Propionibacterium granulosum [49], Staphylococcusaureus[49]andStaphylococcusepidermidis[49]arebacteriapresentontheskinofacne patients. ArecentstudybyLietal.,2015[50]suggeststhattheclinicalefficacyofgreenteapolyphenols may be due to their anti-microbial properties against these bacteria. The study compared topical greenteaextract(EGCGcontentof0.081%),pomegranatejuice,andpomegranateextractinterms oftheiranti-microbialproperties. Theresultsshowedthat98%ofP.acnes,P.granulosum,S.aureus, and S. epidermidis was inhibited at concentrations of 400 µg gallic acid equivalents (GAE)/mL GT orless. In addition to the anti-microbial properties of tea polyphenols, other mechanisms have been proposed to explain the improvement in acne from topical green tea administration. Yoon et al., 2013 [31] postulated that this improvement was due to the modulation of the M locus protein kinase-Sterolregulatoryelement-bindingprotein1(MLPK-SREBP-1)signalingpathway,whichleads toreductioninlipogenesis. Additionally,EGCGincreasedapoptosisoftheSEB-1celllineofsebocytes and led to a reduction in the mean colony forming units of P. acnes. Altogether, these findings further support the notion that EGCG has anti-microbial activity against P. acnes. EGCG was also foundtoreducetranscriptionofthenuclearfactor-κB(NF-kB)pathwayandreduceinflammation. Overall, studies suggest that tea polyphenols exert their effect on sebum production and acne via severalmechanisms,includingactingasanti-microbial,anti-lipogenic,anti-inflammatorymolecules. 4.5. Limitations Interpretationofthisreviewshouldbeconsideredinlightofthelimitednumberofstudiesthat wereavailable. Manyofthestudieshadsmallsamplesizesandsomestudieshadpoorresearchdesign, includingalackofcontrolgroup. Morestudiesofhighqualityareneededtoestablishtheefficacyof teapolyphenolsforcontrollingsebumproduction,aswellaspreventingormanagingacnevulgaris. 5. Conclusions Our search produced a limited number of results for how tea polyphenols may be used in reducingsebumsecretionandacnepathology.Whileallthestudiesusedsomeformofteapolyphenols, theexposureswerenotuniform. Somestudiesincludedunknowntypesofteaandwithunspecified amountsofteapolyphenolsasexposure. However,basedonthisreviewthereissomeevidencethat tea polyphenols used orally and topically may be beneficial for skin health and more specifically, forreducingsebumproductionbythesebaceousglandsandforthepreventionandtreatmentofacne vulgaris. Physiciansandotherhealthcareprofessionalsshouldbeawareofthestudiesexamining thebeneficialeffectsofteapolyphenolsastheycouldpotentiallybeusedasalternativesinskincare. Researchstudiesofhighqualityandwithlargesamplesizesareneededtoassesstheefficacyoftea polyphenolsintopicalandoralpreventionofacnevulgarisandlipidsynthesisbythesebaceousglands. AuthorContributions: SuzanaSaricandRajaK.Sivamaniconceivedanddesignedthereview;SuzanaSaric, ManishaNotay,andRajaK.Sivamanicriticallyevaluatedthearticlesforinclusioninthisreview;SuzanaSaricand ManishaNotaywrotethefirstdraftofthismanuscript;RajaK.Sivamaniperformedcriticaleditingandprovided overalloversightforthereview. ConflictsofInterest:Theauthorsdeclarenoconflictofinterest. Antioxidants2017,6,2 9of16 AppendixA TableA1.Teapolyphenolstudies—summary. Polyphenol Therapy(Topicalor Comparison(or Tea Subtypesand Subjects(n,Age) StudyDesign,Duration MajorOutcomeMeasures MajorResults AdverseEvents Reference Systemic;Dosage) Control/Placebo) Content SebumProductionStudies Single-blinded, placebo-controlled, G1(GTgroup): monocentricstudy; significantreduction Pakistan(months insebumsecretion December-February); frombaselineto 2groups(G): 60daysoftreatment G1:usedGTtopicalonone comparedtoplacebo cheek,placeboontheother; control(p=0.0060) n=11; (27%decrease GTformulation: G2:GT-Ltopicalonone Percentchangeinsebumsecretion frombaseline); 5%greentea; Greentea+Lotus n=22; cheek,placeboontheother; every15days(calculatedbyformula G2(GT-Lgroup): Greentea Mahmoodetal., Greentea GT-Lformulation: (GT)Topical (GT-L)Topical; allhealthymen; n=11. %change=((Dx−D0)/D0)×100; significantreduction Nonereported 2013[15] 2.5%greentea+ PlaceboTopical Age22–28years-old. Interventionlength: Dx=sebumvalueonday15,3045,60; insebumsecretion 2.5%lotusextract. 60days; D0=baselinesebumvalue) frombaselineto Amountofteapolyphenol: 60daysoftreatment informationnotprovided; comparedtoplacebo Frequencyofapplication: control(p=0.0002) oncedailyatbedtime; (25%decrease Followuptime:baseline, frombaseline); day15,30,45,60; Placebo:nosignificant Sebumexcretiononboth effectonreducing cheeksmeasuredwith sebumsecretion. Sebumeterateachvisit. Therapeuticstudy Interventionlength: 60days; Percentchangeinskinsebum 3%GTEformulation Frequencyoftopicaluse: production(calculatedviaformula decreasedsebum n=10; notstated; %change=((A−B)/B)×100 productionbynearly Mahmoodetal., Greentea 3%GTextract Topical Nocontrolgroup Age24to40years-old; Amountoftopical: A=individualvalueofanyparameter 10%atweek1, 2010[34] allhealthymen notstated; (from1stto8thweek); and60%atweek8) Followup:skinsebum B=zerovalueforthatparameter. (p<0.05) productionmeasuredat week1,2,3,4,6,and8 viasebumeter. Antioxidants2017,6,2 10of16 TableA1.Cont. Polyphenol Therapy(Topicalor Comparison(or Tea Subtypesand Subjects(n,Age) StudyDesign,Duration MajorOutcomeMeasures MajorResults AdverseEvents Reference Systemic;Dosage) Control/Placebo) Content AcneStudies Betweengroup comparison:G1vs. G2:significant reductionin inflammatorylesion countsonnose (p=0.03),perioralarea (p=0.04)andchin (p=0.03);no Randomized,doubleblind, differenceintotal placebocontrolledtrial; lesioncount; May2012to n=80; G1didnothave October2013,Taiwan; Amountof Allwomen; significantreduction G1:1subject Interventionlength: teapolyphenols: Age25–45years-old onforehead,cheek developedmild 4weeks; EachGTE withmoderateto andtotallesioncount constipation, Followup:baselineandat capsulecontained: severeacne comparedtoplacebo; 2subjects Systemic 4weeks; 285.6mgEGCG, (determinedby Acnelesioncounts(inflammatoryand Withingroup abdominal DecaffeinatedGTE; G1:receiveddecaffeinated 78.7mgECG, Placebo Investigator’sGlobal non-inflammatory)recordedforentire comparison: discomfortafter Luetal., Greentea eachcapsule500mg GTEfor4weeksn=40; 38.5mgEGC, (cellulose) Assessment(scoreof3 facebyblindeddermatologistat G1:Comparedwith GTEtreatment; 2016[39] decaffeinatedGTE G2:placebo(purecellulose) 24mgEC, or4onascale0to5)); baselineandat4weeks baseline,G1 G2:1subject orcellulose for4weeksn=40; 21.25mgGCG, Noneofthewomen (decaffeinatedGTE) thirsty,1difficulty Productspackagedinto <0.3mgGC, receivedsystemic hadsignificantlylower fallingasleep; identicalcapsulesfor <0.3mgcaffeine, retinoidorhormone numberof Nomajoradverse blindingpurposes; 51.65mgcellulose treatmentduring inflammatorylesions effectsnoted. Frequency:Subjectstook previous3months. onforehead(p=0.04), 1capsule30minafter cheeks(p=0.04)and meals3timesdailyfor entireface(totallesion 4weeks. count)(p=0.003); G2:inplacebogroup, therewassignificant reductionin inflammatorylesion countoncheeks (p=0.01),chin (p=0.01)andentire face(p=0.02).
Description: